Eleven new polyketones named diaporthsins A-K (1-11) were isolated from the fermentation of Diaporthe sp. JC-J7. The chemical structures of compounds (1-11) were elucidated by spectroscopic method, including HRESIMS, 2DNMR, NMR spectra and chemical method. Compound 11 features unusual acyclic polyketone-phenolic polyketone hybrid structure that integrate the characteristics of different fungal metabolites (cytosporone and multiplolide). Compound 3 was the only C 12 -polyketone in this research. These new polyketones showed inhibitory activity on content of triglycerides (TG) in steatosis hepatocyte L-02 cells. Among them, compound 5, and (4E)-6,7,9-trihydroxydec-4-enoic acid display inhibitory activity on content of triglycerides (TG) in steatotic L-02 cells with inhibition ratios of 26%, and 21% at concentration of 5 g/mL, along with inhibition ratios of 8-O-acetylmultiplolide A, and phomopsisporone A at concentration of 5 g/mL were calculated to be about 24 %, and 16 % respectively, which was equivalent to the antihyperlipidemic activity of lovastatin. The preliminary structure-activity relationship stated that the acetyl at C-8 can increase the antihyperlipidemic activity of multiplolide A, and the glycol ester and hydroxyl at C-6 can also raise the corresponding activity of diaporthsin B.
Table of contents
. 1 H NMR spectrum of compound 1 in CDCl 3 (600 MHz) 4 Figure S2 . 13 C NMR spectrum of compound 1 in CDCl 3 (150 MHz) 4 Figure S3 . COSY spectrum of compound 1 in CDCl 3 5 Figure S4 . HSQC spectrum of compound 1 in CDCl 3 (600 MHz) 5 Figure S5 . ROESY spectrum of compound 1 in CDCl 3 6 Figure S6 . HMBC spectrum of compound 1 in CDCl 3 6 Figure S7 . HRESIMS spectrum of compound 1 7 Figure S8 . IR Spectrum of compound 1 7 Figure S9 . 1 H NMR spectrum of compound 2 in MeOD (600 MHz) 8 Figure S10 . 13 C NMR spectrum of compound 2 in MeOD (150 MHz) 8 Figure S11 . COSY spectrum of compound 2 in MeOD 9 Figure S12 . HSQC spectrum of compound 2 in MeOD 9 Figure S13 . ROESY spectrum of compound 2 in MeOD 10 Figure S14 . HMBC spectrum of compound 2 in MeOD 10 Figure S15 . HRESIMS spectrum of compound 2 11 Figure S16 . IR Spectrum of compound 2 11 Figure S17 . 1 H NMR spectrum of compound 3 in MeOD (600 MHz) 12 Figure S18 . 13 C NMR spectrum of compound 3 in MeOD (150 MHz) 12 Figure S19 . COSY spectrum of compound 3 in MeOD 13 Figure S20 . HSQC spectrum of compound 3 in MeOD 13 Figure S21 . ROESY spectrum of compound 3 in MeOD 14 Figure S22 . HMBC spectrum of compound 3 in MeOD 14 Figure S23 . HRESIMS spectrum of compound 3 15 Figure S24 . IR Spectrum of compound 3 15 Figure S25 . 1 H NMR spectrum of compound 4 in MeOD (500 MHz) 16 Figure S26 . 13 Figure S36 . HSQC spectrum of compound 5 21 Figure S37 . NOESY spectrum of compound 5 22 Figure S38 . HMBC spectrum of compound 5 22 Figure S39 . HRESIMS spectrum of compound 5 23 Figure S40 . IR Spectrum of compound 5 23 Figure S41 . 1 H NMR spectrum of compound 6 MeOD (500 MHz) 24 Figure S42 . 13 C NMR spectrum of compound 6 in MeOD (125 MHz) 24 Figure S43 . COSY spectrum of compound 6 in MeOD 25 Figure S44 . HSQC spectrum of compound 6 in MeOD 25 Figure S45 . NOESY spectrum of compound 6 in MeOD 26 Figure S46 . HMBC spectrum of compound 6 in MeOD 26 Figure S47 . HRESIMS spectrum of compound 6 27 Figure S48 . IR Spectrum of compound 6 27 Figure S49 . 1 H NMR spectrum of compound 7 in acetone-d 6 (500 MHz) 28 Figure S50 . 13 C NMR spectrum of compound 7 in acetone-d 6 (125 MHz) 28 Figure S51 . COSY spectrum of compound 7 in acetone-d 6 29 Figure S52 . HSQC spectrum of compound 7 in acetone-d 6 29 Figure S53 . NOESY spectrum of compound 7 in acetone-d 6 30 Figure S54 . HMBC spectrum of compound 7 in acetone-d 6 30 Figure S55 . HRESIMS spectrum of compound 7 31 Figure S56 . IR Spectrum of compound 7 31 Figure S57 . 1 H NMR spectrum of compound 8 in MeOD (600 MHz) 32 Figure S58 . 13 C NMR spectrum of compound 8 in MeOD (150 MHz) 32 Figure S59 . COSY spectrum of compound 8 in MeOD 33 Figure S60 . HSQC spectrum of compound 8 in MeOD 33 Figure S61 . NOESY spectrum of compound 8 in MeOD 34 Figure S62 . HMBC spectrum of compound 8 in MeOD 34 Figure S63 . HRESIMS spectrum of compound 8 35 Figure S64 . IR Spectrum of compound 8 35 Figure S65 . 1 H NMR spectrum of compound 9 in CHCl 3 (600 MHz) 36 Figure S66 . 13 C NMR spectrum of compound 9 in CHCl 3 (150 MHz) 36 Figure S67 . COSY spectrum of compound 9 in CHCl 3 37 Figure S68 . HSQC spectrum of compound 9 in CHCl 3 37 Figure S69 . ROESY spectrum of compound 9 in CHCl 3 38 Figure S70 . HMBC spectrum of compound 9 in CHCl 3 38 Figure S71 . HRESIMS spectrum of compound 9 39 Figure S72 . IR Spectrum of compound 9 39 Figure S73 . 1 H NMR spectrum of compound 10 in acetone-d 6 (600 MHz) 40 Figure S74 . 13 190 191 192 193 194 195 196 197 198 199 Figure S7. Figure S89 . UV Spectrum of compound 11 Figure S90 1 H NMR spectrum of (S)-MTPA ester of 1 in CDCl 3 Figure S91 1 H NMR spectrum of (R)-MTPA ester of 1 in CDCl 3
